NCT06564727

Brief Summary

The objective of this study was to report our experience with U-VATS resection and to evaluate our surgical outcomes with an analysis of postoperative complications. The investigators also estimate the prognostic factors that influence the morbidity and the conversion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

August 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2024

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

3 years

First QC Date

August 14, 2024

Last Update Submit

August 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative complications

    evaluate the complication at 30 days

    30 days

Study Arms (2)

Uniportal VATS approach

EXPERIMENTAL

patient treated by Uniportal VATS technique

Procedure: Uniportal VATS approach

VATS resection

ACTIVE COMPARATOR

patients treated by VATS technique

Procedure: VATS approach

Interventions

Uniportal VATS resection for simple pulmonary aspergilloma

Uniportal VATS approach
VATS approachPROCEDURE

VATS resection for complex pulmonary aspergilloma

VATS resection

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- Treatment using uniportal VATS

You may not qualify if:

  • \- Resection using thoracotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hassan II University

Casablanca, 20000, Morocco

Location

MeSH Terms

Conditions

Pulmonary AspergillosisThoracic Diseases

Condition Hierarchy (Ancestors)

AspergillosisMycosesBacterial Infections and MycosesInfectionsLung Diseases, FungalLung DiseasesRespiratory Tract Diseases

Study Officials

  • sara WAGUAF

    Hassan II University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: study the effect of a treatment and evaluate outcome postoperatively
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

August 14, 2024

First Posted

August 21, 2024

Study Start

January 1, 2017

Primary Completion

January 1, 2020

Study Completion

January 30, 2020

Last Updated

August 21, 2024

Record last verified: 2024-08

Locations